Skip to main content
NHC logo

NHC · National Healthcare Corp

Track NHC — free
Market Cap
$3.48B
Shares
15.66M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$223.31 Open$223.34 Day$221.80–225.29 52W close$117.43–236.75 Avg vol 30d111K Short int747K · 4.8% float · 7.3d Short vol58% DataJan 2020–Sep 2026 Filing10-Q · Aug 6

Up next

filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.56B
Trailing 12 months
Net income (TTM)
$140.18M
Trailing 12 months
Revenue growth YoY
+8.8%
Year over year
Operating margin
9.3%
Trailing 12 months
P / E (TTM)
25.1
Trailing earnings · reciprocal yield 4.0%
FCF yield
4.2%
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+1.7%
Year over year · more shares
Price change (1Y)
+90.5%
Trailing year
Short interest
4.8%
Latest settlement · 7.3 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bullish Fundamentals Excellent Quant / Vol Low
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +23%
above
Price vs 50-day avg +0%
above
RSI (14) 50
neutral
MACD trend Negative
52-week position 89%
near high
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −4%
trailing
6-month return +38%
trailing
YTD return +63%
this year
Relative strength +15%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $223 › 200d $181 — 50d above 200d
Institutional flow Accumulating
+5% holders QoQ · +40 funds added
Insider flow Distributing
Net -$4.5M over 90 days · 100% sells
Short interest Falling
4.77% of float · ▼ -1.3% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
252 holders — near 3-yr high, broad support
Squeeze score 61
elevated · 0–100
Fundamentals
Excellent
Revenue growth +16%
Y/Y
EPS growth +17%
Y/Y
Free cash flow $148.6M
Valuation P/E 25
in line
Buyback $25.0M
authorized
Balance sheet $52.8M
net cash
Quant / Vol
risk profile
Low
Volatility 34%
annualized · 1-yr
Max drawdown −10%
past year
ATR 2.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+23% Bullish
Price vs 50-day avg
+0% Bullish
RSI (14)
50 Neutral
MACD trend
Negative Bearish
52-week position
89% Bullish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $223 › 200d $181 — 50d above 200d
Institutional flow Accumulating
+5% holders QoQ · +40 funds added
Insider flow Distributing
Net -$4.5M over 90 days · 100% sells
Short interest Falling
4.77% of float · ▼ -1.3% MoM · 7.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
252 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $117 Now $223 · 89% Range high $237
vs 200-day avg +23% vs 50-day avg +0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NHC
National Healthcare Corp
this stock
$3.48B +62.9% +16.1% 25.0 4.8%
HCA
HCA Healthcare, Inc.
$95.18B -8.8% +7.1% 14.8 2.8%
FSNUY
Fresenius SE & Co. KGaA
$29.85B -8.7% 0.0%
THC
Tenet Healthcare Corp
$21.10B +31.3% +0.9% 10.1 2.3%
EHC
Encompass Health Corp
$12.17B +14.5% +10.5% 20.1 3.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
252
% held
65.4%
Net QoQ
-79.8K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
286
View
Short & Settlement
Short Interest Falling
Shares short
746.8K
Days to cover
7.3d
Change
-10.1K sh
View
Short Volume
Short vol %
58%
As of
Sep 21, 2026
Short Total
View
Fails to Deliver
FTD shares
21
Value
$4.8K
As of
Aug 18, 2026
View
Off-Exchange
Off-exchange %
37.0%
Week of
Aug 17, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$4.5M
Buyers / Sellers
0 / 5
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.5B
Net income (FY)
$120.0M
EPS diluted
$7.67
View
Buybacks
Authorized
$25.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 11, 2026
This year
16
View
Proposed Sales
Value
$600.8K
Shares
2.7K
Filed
Sep 10, 2026
View

Performance

5D 20D 120D MTD YTD
NHC -2.0% -4.3% +37.5% +3.1% +62.9%
SPY +1.7% +1.0% +22.4% +0.8% +13.4%
vs SPY -3.6% -5.3% +15.1% +2.3% +49.5%

Capital returns

Declared · upcoming
$0.67 / share · ex Sep 30, 2026
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
· no payout in the trailing year
Buyback program · as of Aug 31, 2019
Authorized
$25.00M
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1047335 CUSIP 635906100 13F (30d) 9 filings 8 filers Visit website Investor relations